In the BioHarmony Drug Report Database

"Preview" Icon

Exemestane

Aromasin (exemestane) is a small molecule pharmaceutical. Exemestane was first approved as Aromasin on 1999-10-21. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.

 

Trade Name

 

Aromasin
 

Common Name

 

exemestane
 

ChEMBL ID

 

CHEMBL1200374
 

Indication

 

breast neoplasms
 

Drug Class

 

Antineoplastics (aromatase inhibitors)

Image (chem structure or protein)

Exemestane structure rendering